Ablation with Low-Dose(1.1GBq) and High-Dose(3.7GBq) Radioiodine in Postoperative Low and Intermediate Risk Differentiated Thyroid Cancer

被引：0
|
作者：
Qu, Yuan [1 ]
Huang, Rui [1 ]
Li, Lin [1 ]
机构：
[1] West China Hosp, Chengdu, Sichuan, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1775
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Thyroid remnant ablation in outpatients with 1.1GBq of I-131: measurement of effective dose to caregivers and establishment of safety precautions
    Uchida, K.
    Yoshimura, M.
    Koizumi, K.
    Tokuuye, K.
    Tsutsui, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S321 - S322
  • [22] Thirteen-year Outcome of a Prospective Randomized Phase III study: 1.1 GBq and 3.7 GBq of Radioiodine Are Equally Effective in Ablation Therapy for Papillary and Follicular Thyroid Cancer
    Ahtiainen, V.
    Vaalavirta, L.
    Tenhunen, M.
    Joensuu, H.
    Maenpaa, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S72 - S72
  • [23] Low- and high-dose radioiodine therapy for low-/intermediate-risk differentiated thyroid cancer: a preliminary clinical trial
    Qu, Yuan
    Huang, Rui
    Li, Lin
    ANNALS OF NUCLEAR MEDICINE, 2017, 31 (01) : 71 - 83
  • [24] Low- and high-dose radioiodine therapy for low-/intermediate-risk differentiated thyroid cancer: a preliminary clinical trial
    Yuan Qu
    Rui Huang
    Lin Li
    Annals of Nuclear Medicine, 2017, 31 : 71 - 83
  • [25] Comparison of 1.1 gbq and 2.2 gbq131I activities in patients with low-risk differentiated thyroid cancer requiring postoperative iodine-131 therapy.
    Campenni, A.
    Ruggeri, R.
    Garo, M.
    Raffa, A.
    Siracusa, M.
    Restuccia, G.
    Rappazzo, A.
    Rosarno, H.
    Nicocia, A.
    Cardile, D.
    Ovcaricek, P. Petranovic
    Baldari, S.
    Giovanella, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S171 - S172
  • [26] Low-dose and high-dose 131I therapy for low and intermediate risk differentiated thyroid cancer: a randomized controlled clinical study
    瞿源
    ChinaMedicalAbstracts(InternalMedicine), 2017, 34 (01) : 20 - 21
  • [27] Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer
    Mallick, Ujjal
    Harmer, Clive
    Yap, Beng
    Wadsley, Jonathan
    Clarke, Susan
    Moss, Laura
    Nicol, Alice
    Clark, Penelope M.
    Farnell, Kate
    McCready, Ralph
    Smellie, James
    Franklyn, Jayne A.
    John, Rhys
    Nutting, Christopher M.
    Newbold, Kate
    Lemon, Catherine
    Gerrard, Georgina
    Abdel-Hamid, Abdel
    Hardman, John
    Macias, Elena
    Roques, Tom
    Whitaker, Stephen
    Vijayan, Rengarajan
    Alvarez, Pablo
    Beare, Sandy
    Forsyth, Sharon
    Kadalayil, Latha
    Hackshaw, Allan
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (18): : 1674 - 1685
  • [28] Stimulated serum thyroglobulin but not RAIU level is a prognostic factor for ablation efficacy with a 3.7GBq (100mCi) fixed 131I dose in patients with differentiated thyroid cancer
    Xiao, Liu
    Wang, Yueqi
    Huang, Rui
    Li, Lin
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2021, 24 (01): : 53 - 59
  • [29] Effects of Low-Dose and High-Dose Postoperative Radioiodine Therapy on the Clinical Outcome in Patients with Small Differentiated Thyroid Cancer Having Microscopic Extrathyroidal Extension
    Han, Ji Min
    Kim, Won Gu
    Kim, Tae Yong
    Jeon, Min Ji
    Ryu, Jin-Sook
    Song, Dong Eun
    Hong, Suck Joon
    Shong, Young Kee
    Kim, Won Bae
    THYROID, 2014, 24 (05) : 820 - 825
  • [30] Low Radioiodine Dose in Postoperative Ablation of Residual Thyroid Tissue in Patients with Differentiated Thyroid Carcinoma
    Bourogianni, O.
    Kapsoritakis, N.
    Tsaroucha, A.
    Stahaki, M.
    Papadaki, E.
    Koukouraki, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S437 - S437
12345